Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
Highlights
The global Hemostatic and Tissue Sealing Agents market was valued at US$ 2801.8 million in 2022 and is anticipated to reach US$ 3454.4 million by 2029, witnessing a CAGR of 3.0% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.
In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hemostatic and Tissue Sealing Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic and Tissue Sealing Agents.
The Hemostatic and Tissue Sealing Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hemostatic and Tissue Sealing Agents market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic and Tissue Sealing Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD
Segment by Type
Hemostatic
Sealant Gum
Segment by Application
Minimally Invasive Surgery
General Surgery
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic and Tissue Sealing Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic and Tissue Sealing Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Hemostatic and Tissue Sealing Agents 麻豆原创 Overview
1.1 Product Overview and Scope of Hemostatic and Tissue Sealing Agents
1.2 Hemostatic and Tissue Sealing Agents Segment by Type
1.2.1 Global Hemostatic and Tissue Sealing Agents 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Hemostatic
1.2.3 Sealant Gum
1.3 Hemostatic and Tissue Sealing Agents Segment by Application
1.3.1 Global Hemostatic and Tissue Sealing Agents 麻豆原创 Value by Application: (2023-2029)
1.3.2 Minimally Invasive Surgery
1.3.3 General Surgery
1.3.4 Other
1.4 Global Hemostatic and Tissue Sealing Agents 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Hemostatic and Tissue Sealing Agents Revenue 2018-2029
1.4.2 Global Hemostatic and Tissue Sealing Agents Sales 2018-2029
1.4.3 Global Hemostatic and Tissue Sealing Agents 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Hemostatic and Tissue Sealing Agents 麻豆原创 Competition by Manufacturers
2.1 Global Hemostatic and Tissue Sealing Agents Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Hemostatic and Tissue Sealing Agents Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Hemostatic and Tissue Sealing Agents Average Price by Manufacturers (2018-2023)
2.4 Global Hemostatic and Tissue Sealing Agents Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Product Type & Application
2.7 Hemostatic and Tissue Sealing Agents 麻豆原创 Competitive Situation and Trends
2.7.1 Hemostatic and Tissue Sealing Agents 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostatic and Tissue Sealing Agents Players 麻豆原创 Share by Revenue
2.7.3 Global Hemostatic and Tissue Sealing Agents 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostatic and Tissue Sealing Agents Retrospective 麻豆原创 Scenario by Region
3.1 Global Hemostatic and Tissue Sealing Agents 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hemostatic and Tissue Sealing Agents Global Hemostatic and Tissue Sealing Agents Sales by Region: 2018-2029
3.2.1 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2018-2023
3.2.2 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2024-2029
3.3 Global Hemostatic and Tissue Sealing Agents Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2018-2029
3.3.1 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2018-2023
3.3.2 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2024-2029
3.4 North America Hemostatic and Tissue Sealing Agents 麻豆原创 Facts & Figures by Country
3.4.1 North America Hemostatic and Tissue Sealing Agents 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hemostatic and Tissue Sealing Agents Sales by Country (2018-2029)
3.4.3 North America Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic and Tissue Sealing Agents 麻豆原创 Facts & Figures by Country
3.5.1 Europe Hemostatic and Tissue Sealing Agents 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hemostatic and Tissue Sealing Agents Sales by Country (2018-2029)
3.5.3 Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic and Tissue Sealing Agents 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Hemostatic and Tissue Sealing Agents 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Country (2018-2029)
3.6.3 Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostatic and Tissue Sealing Agents 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Hemostatic and Tissue Sealing Agents 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hemostatic and Tissue Sealing Agents Sales by Country (2018-2029)
3.7.3 Latin America Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic and Tissue Sealing Agents 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic and Tissue Sealing Agents 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2018-2029)
4.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2018-2023)
4.1.2 Global Hemostatic and Tissue Sealing Agents Sales by Type (2024-2029)
4.1.3 Global Hemostatic and Tissue Sealing Agents Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2018-2029)
4.2.1 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2018-2023)
4.2.2 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2024-2029)
4.2.3 Global Hemostatic and Tissue Sealing Agents Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Hemostatic and Tissue Sealing Agents Price by Type (2018-2029)
5 Segment by Application
5.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2018-2029)
5.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2018-2023)
5.1.2 Global Hemostatic and Tissue Sealing Agents Sales by Application (2024-2029)
5.1.3 Global Hemostatic and Tissue Sealing Agents Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2018-2029)
5.2.1 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2018-2023)
5.2.2 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2024-2029)
5.2.3 Global Hemostatic and Tissue Sealing Agents Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Hemostatic and Tissue Sealing Agents Price by Application (2018-2029)
6 Key Companies Profiled
6.1 J&J
6.1.1 J&J Corporation Information
6.1.2 J&J Description and Business Overview
6.1.3 J&J Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.1.4 J&J Hemostatic and Tissue Sealing Agents Product Portfolio
6.1.5 J&J Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter Hemostatic and Tissue Sealing Agents Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 C R Bard
6.3.1 C R Bard Corporation Information
6.3.2 C R Bard Description and Business Overview
6.3.3 C R Bard Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.3.4 C R Bard Hemostatic and Tissue Sealing Agents Product Portfolio
6.3.5 C R Bard Recent Developments/Updates
6.4 B Braun
6.4.1 B Braun Corporation Information
6.4.2 B Braun Description and Business Overview
6.4.3 B Braun Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 B Braun Hemostatic and Tissue Sealing Agents Product Portfolio
6.4.5 B Braun Recent Developments/Updates
6.5 Integra Life Sciences
6.5.1 Integra Life Sciences Corporation Information
6.5.2 Integra Life Sciences Description and Business Overview
6.5.3 Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Integra Life Sciences Hemostatic and Tissue Sealing Agents Product Portfolio
6.5.5 Integra Life Sciences Recent Developments/Updates
6.6 Advance Medical Solution
6.6.1 Advance Medical Solution Corporation Information
6.6.2 Advance Medical Solution Description and Business Overview
6.6.3 Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Advance Medical Solution Hemostatic and Tissue Sealing Agents Product Portfolio
6.6.5 Advance Medical Solution Recent Developments/Updates
6.7 CSL Behring
6.6.1 CSL Behring Corporation Information
6.6.2 CSL Behring Description and Business Overview
6.6.3 CSL Behring Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CSL Behring Hemostatic and Tissue Sealing Agents Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 CryoLife
6.8.1 CryoLife Corporation Information
6.8.2 CryoLife Description and Business Overview
6.8.3 CryoLife Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CryoLife Hemostatic and Tissue Sealing Agents Product Portfolio
6.8.5 CryoLife Recent Developments/Updates
6.9 Zimmer Biomet
6.9.1 Zimmer Biomet Corporation Information
6.9.2 Zimmer Biomet Description and Business Overview
6.9.3 Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zimmer Biomet Hemostatic and Tissue Sealing Agents Product Portfolio
6.9.5 Zimmer Biomet Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pfizer Hemostatic and Tissue Sealing Agents Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Medtronic
6.11.1 Medtronic Corporation Information
6.11.2 Medtronic Hemostatic and Tissue Sealing Agents Description and Business Overview
6.11.3 Medtronic Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Medtronic Hemostatic and Tissue Sealing Agents Product Portfolio
6.11.5 Medtronic Recent Developments/Updates
6.12 Smith & Nephew
6.12.1 Smith & Nephew Corporation Information
6.12.2 Smith & Nephew Hemostatic and Tissue Sealing Agents Description and Business Overview
6.12.3 Smith & Nephew Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Smith & Nephew Hemostatic and Tissue Sealing Agents Product Portfolio
6.12.5 Smith & Nephew Recent Developments/Updates
6.13 Cohera Medical
6.13.1 Cohera Medical Corporation Information
6.13.2 Cohera Medical Hemostatic and Tissue Sealing Agents Description and Business Overview
6.13.3 Cohera Medical Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Cohera Medical Hemostatic and Tissue Sealing Agents Product Portfolio
6.13.5 Cohera Medical Recent Developments/Updates
6.14 Shanghai Haohai Biological Technology Co. Ltd.
6.14.1 Shanghai Haohai Biological Technology Co. Ltd. Corporation Information
6.14.2 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Description and Business Overview
6.14.3 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product Portfolio
6.14.5 Shanghai Haohai Biological Technology Co. Ltd. Recent Developments/Updates
6.15 Shandong Saikesaisi Biotechnology Co., Ltd
6.15.1 Shandong Saikesaisi Biotechnology Co., Ltd Corporation Information
6.15.2 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Description and Business Overview
6.15.3 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product Portfolio
6.15.5 Shandong Saikesaisi Biotechnology Co., Ltd Recent Developments/Updates
6.16 Chang ShaHai Run biological technology Co, LTD
6.16.1 Chang ShaHai Run biological technology Co, LTD Corporation Information
6.16.2 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Description and Business Overview
6.16.3 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product Portfolio
6.16.5 Chang ShaHai Run biological technology Co, LTD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic and Tissue Sealing Agents Industry Chain Analysis
7.2 Hemostatic and Tissue Sealing Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic and Tissue Sealing Agents Production Mode & Process
7.4 Hemostatic and Tissue Sealing Agents Sales and 麻豆原创ing
7.4.1 Hemostatic and Tissue Sealing Agents Sales Channels
7.4.2 Hemostatic and Tissue Sealing Agents Distributors
7.5 Hemostatic and Tissue Sealing Agents Customers
8 Hemostatic and Tissue Sealing Agents 麻豆原创 Dynamics
8.1 Hemostatic and Tissue Sealing Agents Industry Trends
8.2 Hemostatic and Tissue Sealing Agents 麻豆原创 Drivers
8.3 Hemostatic and Tissue Sealing Agents 麻豆原创 Challenges
8.4 Hemostatic and Tissue Sealing Agents 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD
听
听
*If Applicable.
